Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
| Title: | Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma |
|---|---|
| Authors: | Villa, Diego *, *, Hoster, Eva *, Hermine, Olivier, Klapper, Wolfram, Szymczyk, Michal, Bosly, André, Unterhalt, Michael, Rimsza, Lisa M., Ramsower, Colleen A., Freeman, Ciara L., Scott, David W., Gerrie, Alina S., Savage, Kerry J., Sehn, Laurie H., Dreyling, Martin |
| Source: | In Blood Advances 27 September 2022 6(18):5285-5294 |
| Database: | ScienceDirect |
Be the first to leave a comment!